Trading in shares of Wakefield Health on the New Zealand stock exchange has been halted this morning, "pending a material announcement".
The company reported pressure on earnings in its report, for the half year to September 30, but is lightly geared at 8.8% debt to equity, and said in the half-year report that Wakefield "continues to explore opportunities for growth through merger or acquisition".
It is also in the midst of major capital works to redevelop Wellington's Bowen Hospital.
Wakefield shares last traded at $7.04, having fallen 21.78% in the last six months, but risen slightly (2.9%) in the last week.
“The change in tone in global financial markets and websites in the past two weeks has been sudden and alarming and I must comment on the change.
As reluctant as I am to be swayed too much by emotion it seems the recent appearance of the “Hindenburg Omen‘ has the major American markets quite mesmerised and [...]” Wayne LochoreMore »